2
Clinical Trials associated with Recombinant bovine basic fibroblast growth factor(Nanchang University)Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis:An Open, Randomized, Controlled, Prospective Study
Radiation therapy is one of the treatments for Nasopharyngeal carcinoma . The most common side effects of post-radiation may be radiation-induced oral mucositis . When severe, oral mucositis increases the risk of infection and may affect clinical outcomes due to treatment interruption, dose reduction, and reduced treatment compliance. In China, a quadruple mixture of dexamethasone, gentamicin, vitamin B12, and lidocaine is commonly used in patients who begin to have radiation-induced oral mucositis . However, the incidence of radiation-induced oral mucositis remains high. Recombinant bovine basic fibroblast growth factor is a multifunctional cell growth factor that stimulates the growth of cells derived from mesoderm and neuroectodermal cells and thus has a wide range of biological activities. The drug has different degrees of promotion on the three stages of the wound repair process, namely the local inflammatory reaction stage, cell proliferation and differentiation, granulation tissue formation stage and tissue reconstruction stage. The purpose of this randomized controlled trial was to evaluate the efficacy of recombinant bovine basic fibroblast growth factor as an intervention in radiation-induced oral mucositis for the treatment of nasopharyngeal carcinoma , with a commonly used quadruple mixture (from dexamethasone, gentamicin , vitamin B12 and lidocaine composition) were compared.
Sequential therapy for mites folliculitis using ornidazole, betamethasone, and recombinant bovine basic fibroblast growth factor
Start Date15 May 2014 |
Sponsor / Collaborator- |
100 Clinical Results associated with Recombinant bovine basic fibroblast growth factor(Nanchang University)
100 Translational Medicine associated with Recombinant bovine basic fibroblast growth factor(Nanchang University)
100 Patents (Medical) associated with Recombinant bovine basic fibroblast growth factor(Nanchang University)
100 Deals associated with Recombinant bovine basic fibroblast growth factor(Nanchang University)